Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases

BACKGROUND: Clinical biomarkers for brain metastases remain elusive. Increased availability of genomic profiling has brought discovery of these biomarkers to the forefront of research interests. METHOD: In this single institution retrospective series, 130 patients presenting with brain metastasis se...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulhaleem, Mohammed, Hunting, John C., Wang, Yuezhu, Smith, Margaret R., Agostino, Ralph D’ jr., Lycan, Thomas, Farris, Michael K., Ververs, James, Lo, Hui-Wen, Watabe, Kounosuke, Topaloglu, Umit, Li, Wencheng, Whitlow, Christopher, Su, Jing, Wang, Ge, Chan, Michael D., Xing, Fei, Ruiz, Jimmy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661935/
https://www.ncbi.nlm.nih.gov/pubmed/38023147
http://dx.doi.org/10.3389/fonc.2023.1214126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661935/
https://www.ncbi.nlm.nih.gov/pubmed/38023147
http://dx.doi.org/10.3389/fonc.2023.1214126

Ejemplares similares